How Specific Are Antibody Drugs?
Hosted Virtually , United StatesAre conventional specificity tools missing critical off-target interactions? Recent findings suggest that up to one-third of antibody drugs display off-target binding, raising concerns about drug attrition and patient safety. Could better tools improve approvals and mitigate risks? 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗳𝗼𝗿 𝗮 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝘄𝗶𝘁𝗵 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝗹 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿, exploring how cell-based protein arrays are emerging as a powerful […]